[Translation] Clinical trial of safety and efficacy of Jinxiang Shugan Tablets in the treatment of mild to moderate depression (syndrome of liver stagnation and spleen deficiency)
1.评价金香疏肝片在更广泛人群中应用于轻、中度抑郁症(肝郁脾虚证)的安全性。 2.评价金香疏肝片治疗轻、中度抑郁症(肝郁脾虚证)的有效性,并且观察在治疗过程中对睡眠障碍、功能性消化不良主要症状的改善情况。
3.分析金香疏肝片临床效果的异质性,包括人群异质性和治疗异质性,为合理指导金香疏肝片的临床应用提供科学的指导意见。
[Translation] 1. To evaluate the safety of Jinxiang Shugan Tablets in mild to moderate depression (syndrome of liver stagnation and spleen deficiency) in a wider population. 2. To evaluate the effectiveness of Jinxiang Shugan Tablets in treating mild to moderate depression (syndrome of liver stagnation and spleen deficiency), and to observe the improvement of the main symptoms of sleep disturbance and functional dyspepsia during the treatment.
3. To analyze the heterogeneity of clinical effects of Jinxiang Shugan Tablets, including population heterogeneity and treatment heterogeneity, to provide scientific guidance for rationally guiding the clinical application of Jinxiang Shugan Tablets.